323 related articles for article (PubMed ID: 19214307)
1. Targeting exofacial protein thiols with Gd(III) complexes. An efficient procedure for MRI cell labelling.
Digilio G; Catanzaro V; Fedeli F; Gianolio E; Menchise V; Napolitano R; Gringeri C; Aime S
Chem Commun (Camb); 2009 Feb; (8):893-5. PubMed ID: 19214307
[TBL] [Abstract][Full Text] [Related]
2. Exofacial protein thiols as a route for the internalization of Gd(III)-based complexes for magnetic resonance imaging cell labeling.
Digilio G; Menchise V; Gianolio E; Catanzaro V; Carrera C; Napolitano R; Fedeli F; Aime S
J Med Chem; 2010 Jul; 53(13):4877-90. PubMed ID: 20533827
[TBL] [Abstract][Full Text] [Related]
3. Gadolinium(III)-based blood-pool contrast agents for magnetic resonance imaging: status and clinical potential.
Mohs AM; Lu ZR
Expert Opin Drug Deliv; 2007 Mar; 4(2):149-64. PubMed ID: 17335412
[TBL] [Abstract][Full Text] [Related]
4. In vivo labeling of B16 melanoma tumor xenograft with a thiol-reactive gadolinium based MRI contrast agent.
Menchise V; Digilio G; Gianolio E; Cittadino E; Catanzaro V; Carrera C; Aime S
Mol Pharm; 2011 Oct; 8(5):1750-6. PubMed ID: 21780833
[TBL] [Abstract][Full Text] [Related]
5. Strategies for increasing the sensitivity of gadolinium based MRI contrast agents.
Caravan P
Chem Soc Rev; 2006 Jun; 35(6):512-23. PubMed ID: 16729145
[TBL] [Abstract][Full Text] [Related]
6. A new class of macrocyclic lanthanide complexes for cell labeling and magnetic resonance imaging applications.
Zheng Q; Dai H; Merritt ME; Malloy C; Pan CY; Li WH
J Am Chem Soc; 2005 Nov; 127(46):16178-88. PubMed ID: 16287307
[TBL] [Abstract][Full Text] [Related]
7. Insights into the use of paramagnetic Gd(III) complexes in MR-molecular imaging investigations.
Aime S; Cabella C; Colombatto S; Geninatti Crich S; Gianolio E; Maggioni F
J Magn Reson Imaging; 2002 Oct; 16(4):394-406. PubMed ID: 12353255
[TBL] [Abstract][Full Text] [Related]
8. Method for enhancing cell penetration of Gd3+-based MRI contrast agents by conjugation with hydrophobic fluorescent dyes.
Yamane T; Hanaoka K; Muramatsu Y; Tamura K; Adachi Y; Miyashita Y; Hirata Y; Nagano T
Bioconjug Chem; 2011 Nov; 22(11):2227-36. PubMed ID: 21985057
[TBL] [Abstract][Full Text] [Related]
9. Efficient relaxivity enhancement in dendritic gadolinium complexes: effective motional coupling in medium molecular weight conjugates.
Fulton DA; O'Halloran M; Parker D; Senanayake K; Botta M; Aime S
Chem Commun (Camb); 2005 Jan; (4):474-6. PubMed ID: 15654374
[TBL] [Abstract][Full Text] [Related]
10. Pushing the sensitivity envelope of lanthanide-based magnetic resonance imaging (MRI) contrast agents for molecular imaging applications.
Aime S; Castelli DD; Crich SG; Gianolio E; Terreno E
Acc Chem Res; 2009 Jul; 42(7):822-31. PubMed ID: 19534516
[TBL] [Abstract][Full Text] [Related]
11. Effect of size and charge on pharmacokinetics and in vivo MRI contrast enhancement of biodegradable polydisulfide Gd(III) complexes.
Zong Y; Guo J; Ke T; Mohs AM; Parker DL; Lu ZR
J Control Release; 2006 May; 112(3):350-6. PubMed ID: 16631270
[TBL] [Abstract][Full Text] [Related]
12. Probing the water coordination of protein-targeted MRI contrast agents by pulsed ENDOR spectroscopy.
Zech SG; Sun WC; Jacques V; Caravan P; Astashkin AV; Raitsimring AM
Chemphyschem; 2005 Dec; 6(12):2570-7. PubMed ID: 16294353
[TBL] [Abstract][Full Text] [Related]
13. Speciation analysis of gadolinium-based MRI contrast agents in blood plasma by hydrophilic interaction chromatography/electrospray mass spectrometry.
Künnemeyer J; Terborg L; Nowak S; Scheffer A; Telgmann L; Tokmak F; Günsel A; Wiesmüller G; Reichelt S; Karst U
Anal Chem; 2008 Nov; 80(21):8163-70. PubMed ID: 18821778
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and characterization of novel natural product-Gd(III) MRI contrast agent conjugates.
Efthimiadou EK; Katsarou ME; Fardis M; Zikos C; Pitsinos EN; Kazantzis A; Leondiadis L; Sagnou M; Vourloumis D
Bioorg Med Chem Lett; 2008 Dec; 18(23):6058-61. PubMed ID: 18938075
[TBL] [Abstract][Full Text] [Related]
15. Gadolinium(III) complexes as MRI contrast agents: ligand design and properties of the complexes.
Hermann P; Kotek J; Kubícek V; Lukes I
Dalton Trans; 2008 Jun; (23):3027-47. PubMed ID: 18521444
[TBL] [Abstract][Full Text] [Related]
16. NMR structural studies of the supramolecular adducts between a liver cytosolic bile acid binding protein and gadolinium(III)-chelates bearing bile acids residues: molecular determinants of the binding of a hepatospecific magnetic resonance imaging contrast agent.
Assfalg M; Gianolio E; Zanzoni S; Tomaselli S; Russo VL; Cabella C; Ragona L; Aime S; Molinari H
J Med Chem; 2007 Nov; 50(22):5257-68. PubMed ID: 17915850
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and characterization of a Gd(III) based contrast agent responsive to thiol containing compounds.
Carrera C; Digilio G; Baroni S; Burgio D; Consol S; Fedeli F; Longo D; Mortillaro A; Aime S
Dalton Trans; 2007 Nov; (43):4980-7. PubMed ID: 17992283
[TBL] [Abstract][Full Text] [Related]
18. Peptide derivatized lamellar aggregates as target-specific MRI contrast agents.
Tesauro D; Accardo A; Gianolio E; Paduano L; Teixeira J; Schillén K; Aime S; Morelli G
Chembiochem; 2007 May; 8(8):950-5. PubMed ID: 17469087
[TBL] [Abstract][Full Text] [Related]
19. Fast and easy access to efficient bifunctional chelators for MRI applications.
Gugliotta G; Botta M; Giovenzana GB; Tei L
Bioorg Med Chem Lett; 2009 Jul; 19(13):3442-4. PubMed ID: 19477128
[TBL] [Abstract][Full Text] [Related]
20. Cyclodextrin-based bimodal fluorescence/MRI contrast agents: an efficient approach to cellular imaging.
Kotková Z; Kotek J; Jirák D; Jendelová P; Herynek V; Berková Z; Hermann P; Lukes I
Chemistry; 2010 Sep; 16(33):10094-102. PubMed ID: 20583046
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
